Tang Capital Management as of March 31, 2012
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 28 positions in its portfolio as reported in the March 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ardea Biosciences | 19.9 | $86M | 3.9M | 21.76 | |
| Nektar Therapeutics note 3.250% 9/2 | 18.6 | $80M | 79M | 1.01 | |
| Amylin Pharmaceuticals | 10.3 | $44M | 1.8M | 24.96 | |
| Pdl Biopharma Inc note 2.875% 2/1 | 9.7 | $42M | 38M | 1.11 | |
| Spectrum Pharmaceuticals | 5.2 | $23M | 1.8M | 12.63 | |
| Mannkind Corp note 3.750%12/1 | 5.2 | $22M | 40M | 0.56 | |
| DepoMed | 4.5 | $20M | 3.1M | 6.26 | |
| Dendreon Corp note | 3.7 | $16M | 20M | 0.81 | |
| Salix Pharmaceuticals | 3.7 | $16M | 300k | 52.50 | |
| Intermune Inc note 2.500% 9/1 | 3.5 | $15M | 17M | 0.89 | |
| OncoGenex Pharmaceuticals | 2.6 | $11M | 833k | 13.29 | |
| Savient Pharmaceuticals note | 2.3 | $9.9M | 24M | 0.42 | |
| MannKind Corporation | 1.5 | $6.5M | 2.6M | 2.47 | |
| Biomarin Pharmaceutical Inc bond cv | 1.5 | $6.4M | 3.0M | 2.13 | |
| Alexza Pharmaceuticals | 1.4 | $6.0M | 9.7M | 0.62 | |
| Vanda Pharmaceuticals (VNDA) | 1.3 | $5.5M | 1.2M | 4.79 | |
| Dendreon Corp cnv | 1.2 | $5.2M | 4.0M | 1.29 | |
| Achillion Pharmaceuticals | 1.0 | $4.3M | 450k | 9.58 | |
| Endocyte | 0.5 | $2.3M | 466k | 4.98 | |
| BioSante Pharmaceuticals | 0.5 | $1.9M | 2.8M | 0.68 | |
| AVANIR Pharmaceuticals | 0.4 | $1.8M | 513k | 3.42 | |
| Nektar Therapeutics (NKTR) | 0.4 | $1.6M | 200k | 7.92 | |
| Human Genome Sciences | 0.3 | $1.3M | 159k | 8.24 | |
| Cadence Pharmaceuticals | 0.3 | $1.1M | 300k | 3.70 | |
| Dendreon Corporation | 0.2 | $848k | 80k | 10.65 | |
| Neoprobe | 0.2 | $810k | 247k | 3.28 | |
| Cyclacel Pharmaceuticals Inc pfd conv ex 6% (CYCCP) | 0.2 | $703k | 278k | 2.53 | |
| Savient Pharmaceuticals | 0.1 | $408k | 187k | 2.18 |
